Stomach cancer is one of the more dangerous cancers, with an overall 5-year survival rate of about 36%. That means roughly one in three people diagnosed with stomach cancer will be alive five years later. The outlook varies enormously depending on when the cancer is caught, ranging from a nearly 78% survival rate for early-stage disease down to just 8% when it has spread to distant organs.
Why Stage at Diagnosis Matters So Much
The single biggest factor determining whether stomach cancer is survivable is how far it has spread by the time it’s found. The National Cancer Institute’s SEER database breaks this into three categories:
- Localized (still in the stomach only): 78.1% five-year survival
- Regional (spread to nearby lymph nodes or organs): 39.0% five-year survival
- Distant (spread to other parts of the body): 8.1% five-year survival
The gap between localized and distant disease is stark. A person whose cancer is caught before it leaves the stomach has roughly ten times the survival rate of someone diagnosed after it has metastasized. Unfortunately, stomach cancer rarely causes obvious symptoms early on, which means many people aren’t diagnosed until the cancer has already spread.
Why It’s Often Caught Late
In its early stages, stomach cancer either produces no symptoms at all or causes vague problems like indigestion and upper belly pain. These are so common in everyday life that most people, and even many doctors, don’t immediately suspect cancer.
The more alarming symptoms tend to show up only after the disease has progressed. These include unintentional weight loss, severe fatigue, vomiting blood, and black or tarry stools. By the time these signs appear, the cancer has often moved beyond the stomach wall. This late-symptom pattern is the core reason stomach cancer carries such a high mortality rate compared to cancers that produce earlier warning signs.
Other symptoms to be aware of at any stage include trouble swallowing, feeling full after eating only a small amount, bloating after meals, persistent heartburn, nausea, and unexplained loss of appetite.
How Screening Changes the Picture
Countries that screen for stomach cancer routinely have dramatically better outcomes. Japan and South Korea, where the disease is more common, run national screening programs offering endoscopy or imaging exams to adults starting at age 40 or 50. The results are striking: Japan reports a 5-year survival rate of about 65%, and South Korea reaches 71.5%, compared to the 36% overall rate in the United States.
Japan’s death rate from stomach cancer dropped from 32.2 per 100,000 in 1990 to 14.1 per 100,000 in 2019, largely because screening catches tumors while they’re still localized and curable. The U.S. does not have a routine screening program for stomach cancer because it’s less common here, which contributes to the lower survival rates for those who do develop it.
What Happens After Surgery
For cancers caught early or at a regional stage, surgery to remove part or all of the stomach is the primary treatment. This can be curative, but recurrence is a real concern. In one large study of patients who underwent surgery intended to cure their cancer, about 20.5% experienced a recurrence.
The period after surgery also carries its own risks. Patients who have had stomach surgery, chemotherapy, or radiation face a significantly higher risk of serious infections. The risk of dying from blood infections (septicemia) is nearly three times higher than in the general population, particularly in the first years after diagnosis. Poor nutritional status, which is common after stomach surgery, compounds this risk.
Age and Survival
Younger patients generally fare better than older ones. Among people with metastatic stomach cancer, those diagnosed at age 44 or younger had a median survival of 6 months, while those 75 and older had a median survival of just 3 months. Mortality increases steadily with age at diagnosis, likely because older patients have fewer treatment options, more coexisting health conditions, and less physiological reserve to tolerate aggressive therapy.
How Treatment Has Improved Outcomes
For advanced stomach cancer that can’t be removed surgically, treatment has improved modestly in recent years. Newer immunotherapy drugs, when combined with standard chemotherapy as a first-line treatment, have extended median survival from about 11 to 14 months in clinical trials. For certain tumor types that produce specific proteins on their surface, targeted therapies have pushed median survival from around 8 months to 12.5 months.
These gains are real but measured in months rather than years. Advanced stomach cancer remains very difficult to treat. The improvements matter most for quality of life and giving patients more functional time, but they haven’t yet transformed advanced disease into something curable for most people.
Other Causes of Death After Diagnosis
Not everyone with stomach cancer dies from the cancer itself. Heart disease is the most common non-cancer cause of death, accounting for about 5.7% of deaths in stomach cancer patients. Cerebrovascular disease and pneumonia also contribute. Notably, people diagnosed with stomach cancer have three times the expected rate of death by suicide compared to the general population, highlighting the psychological toll of the diagnosis. The risk of fatal blood infections is also nearly three times higher than normal, particularly for patients undergoing treatment.
These numbers underscore that stomach cancer affects the whole body and the whole person, not just the stomach. Nutritional decline, blood clotting abnormalities, immune suppression from treatment, and mental health challenges all play a role in overall mortality.